The newsfeed available here is provided by our content partner EQS Group. This is one of the most important and widest-reaching press services in the D-A-CH region, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
System-State: Number of processed items 49.065 Notifications successully processed since Inception
Der EQS-Newsfeed ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
Following the previous year's record result, HBM Healthcare Investments experienced a slight decline in value in the 2021/22 financial year ended on 31 March 2022. The net asset value (NAV) per share fell by 3.6 percent to CHF 285.53. The share price declined disproportionately by 13.2 percent to CHF 276.00.
The healthcare sector showed a mixed pi...
HBM Healthcare Investments generated a net profit of CHF 4 million in the reporting quarter ended 31 December 2021. For the first nine months of the 2021/2022 financial year, the net profit amounts to CHF 275 million. Although the biotech stock market in general declined, several portfolio companies announced operational successes, which resulted i...
HBM Healthcare Investments closes the 2021 calendar year with another strong performance. The net asset value per share (NAV) rose by 19 percent to CHF 336.27 as at 31 December 2021, while the share price increased by 15.2 percent to close at CHF 339.00 at a small premium to NAV.
The healthcare sector showed a mixed picture in terms of performance...
EQS Group-News: HBM Healthcare Investments AG
/ Key word(s): IPO
HBM Healthcare Investments benefits from the IPO of portfolio company IO Biotech
08.11.2021 / 06:46
IO Biotech (Nasdaq: IOBT), a so far privately held company in the HBM Healthcare Investments portfolio, issued 7.15 million new shares at a price of USD 14.00 per sh...
HBM Healthcare Investments generated for the first half of the financial year from 1 April to 30 September 2021, a profit of CHF 271 million while NAV increased by 12.6 percent to CHF 335.64. The share price rose 6.0 percent to CHF 340.00.
The main drivers were positive changes in the value of private companies and of public companies originating ...
Consequat mollit laboris sit voluptate duis duis mollit irure labore eu excepteur sit. Laboris cupidatat ullamco duis pariatur consequat culpa consectetur ex deserunt irure aute. Occaecat voluptate quis reprehenderit commodo minim aliquip sunt sint mollit. Magna enim ullamco amet ipsum cillum quis ipsum consectetur Lorem nostrud esse nisi. Nisi ut officia culpa ad id magna est aliqua consectetur est.
Report a bug
Important note
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .
xMas Holidays
